Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Oct;191(10):2467-2481.
doi: 10.1002/ajmg.a.63346. Epub 2023 Jul 24.

Neurofibromatosis- and schwannomatosis-associated tumors: Approaches to genetic testing and counseling considerations

Allison Goetsch Weisman  1   2 , Shelly Weiss McQuaid  1   2   3 , Heather B Radtke  4   5 , Jessica Stoll  6 , Bryce Brown  7 , Alicia Gomes  7
Affiliations
Review

Neurofibromatosis- and schwannomatosis-associated tumors: Approaches to genetic testing and counseling considerations

Allison Goetsch Weisman et al. Am J Med Genet A. 2023 Oct.

Abstract

Neurofibromatosis (NF) and schwannomatosis (SWN) are genetic conditions characterized by the risk of developing nervous system tumors. Recently revised diagnostic criteria include the addition of genetic testing to confirm a pathogenic variant, as well as to detect the presence of mosaicism. Therefore, the use and interpretation of both germline and tumor-based testing have increasing importance in the diagnostic approach, treatment decisions, and risk stratification of these conditions. This focused review discusses approaches to genetic testing of NF- and SWN-related tumor types, which are somewhat rare and perhaps lesser known to non-specialized clinicians. These include gastrointestinal stromal tumors, breast cancer, plexiform neurofibromas with or without transformation to malignant peripheral nerve sheath tumors, gliomas, and schwannomas, and emphasizes the need for inclusion of genetic providers in patient care and appropriate pre- and post-test education, genetic counseling, and focused evaluation by a medical geneticist or other healthcare provider familiar with clinical manifestations of these disorders.

Keywords: breast cancer; gastrointestinal stromal tumor; genetic counseling; genetic testing; glioma; neurofibromatosis; plexiform neurofibroma; schwannoma; schwannomatosis.

PubMed Disclaimer

References

REFERENCES

    1. Alaidarous, A., Parfait, B., Ferkal, S., Cohen, J., Wolkenstein, P., & Mazereeuw-Hautier, J. (2019). Segmental schwannomatosis: characteristics in 12 patients. Orphanet Journal of Rare Diseases, 14(1), 207.
    1. Bacci, C., Sestini, R., Provenzano, A., Paganini, I., Mancini, I., Porfirio, B., Vivarelli, R., Genuardi, M., & Papi, L. (2010). Schwannomatosis associated with multiple meningiomas due to a familial SMARCB1 mutation. Neurogenetics, 11(1), 73-80.
    1. Baser, M. E., Friedman, J. M., & Evans, D. G. (2006). Increasing the specificity of diagnostic criteria for schwannomatosis. Neurology, 66(5), 730-732.
    1. Bates, J. E., Peterson, C. R., Dhakal, S., Giampoli, E. J., & Constine, L. S. (2014). Malignant peripheral nerve sheath tumors (MPNST): a SEER analysis of incidence across the age spectrum and therapeutic interventions in the pediatric population. Pediatric Blood & Cancer, 61(11), 1955-1960.
    1. Beert, E., Brems, H., Daniëls, B., de Wever, I., van Calenbergh, F., Schoenaers, J., Debiec-Rychter, M., Gevaert, O., de Raedt, T., van den Bruel, A., de Ravel, T., Cichowski, K., Kluwe, L., Mautner, V., Sciot, R., & Legius, E. (2011). Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumors. Genes, Chromosomes & Cancer, 50(12), 1021-1032.

Supplementary concepts